Media Summary: A presentation and panel discuss potential gaps in A presentation and panel discuss new analytical methods that are promising for generic drug development, screening, and ... A presentation and panel assess analytical methods currently considered most useful and how to better develop these ...
Complex Product Characterization Analysis Session - Detailed Analysis & Overview
A presentation and panel discuss potential gaps in A presentation and panel discuss new analytical methods that are promising for generic drug development, screening, and ... A presentation and panel assess analytical methods currently considered most useful and how to better develop these ... Asif Rasheed from the Office of Pharmaceutical Quality discusses common issues and challenges for Yiwei Li from CDER's Office of Pharmaceutical Quality shares a case study, an introduction to Iron Colloid Drug Xiaoming Xu from the CDER Office of Pharmaceutical Division of
CDER Office of Generic Drugs (OGD)'s Andrew LeBoeuf and Kimberly Witzmann provide a general overview of combination ... Rachel Dunn, PhD, Director of the Division of Pharmaceutical Unlock a clear, step-by-step understanding of the FDA requirements for peptide In this audiocast, we discover the cutting-edge analytical tools that are revolutionizing the In the race to bring a new biotherapeutic to market, unexpected obstacles can slow you down or even knock you back a few steps.
